Cytosystems Invited to MEDICA Trade Fair

Cytosystems has been invited to attend the MEDICA trade fair brokerage and pitching events in Dusseldorf 13th-16th November through their involvement in the EU Horizon 2020 scheme. The €3.2million grant which was awarded in 2015 has allowed the company to continue in their development of bladder cancer diagnostics and look towards a full clinical trial of their first product BladderLight™.

To coincide with their attendance at the trade fair, a new brochure presented by Cytosystems describes, for the first time, their technology solution for bladder cancer stratification through their product BladderLight™. BladderLight™, an integrated and automated digital pathology solution for the diagnosis and monitoring of bladder cancer, marks a step-change in non-invasive bladder cancer diagnostics.

Comprising of three component technologies, BladderLight™ provides superior accuracy by optimising each step in the diagnostic workflow, mitigating the current limitations of urine cytology and biomarker analysis.

The brochure highlights Cytosystems’ technology for cell analysis and outlines the benefits of adopting BladderLight™. It is to be introduced into the public domain during the MEDICA trade fair in Dusseldorf. Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. if you would like a copy.